DAVANGERE (11)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces changes to securities under Short Term ASM framework effective January 22, 2026, including additions, removals, and stage … | |||||||||||||||
BSE announces changes to securities under Short Term ASM framework effective January 22, 2026, including additions, removals, and stage modifications.
| |||||||||||||||
Companies provide clarifications on significant increases in trading volume and price movements, stating they are market-driven with no … | |||||||||||||||
Companies provide clarifications on significant increases in trading volume and price movements, stating they are market-driven with no undisclosed price-sensitive information.
| |||||||||||||||
Companies provide clarifications on significant volume and price movements in their securities, stating movements are market-driven with no … | |||||||||||||||
Companies provide clarifications on significant volume and price movements in their securities, stating movements are market-driven with no undisclosed price-sensitive information.
| |||||||||||||||
NSE circular on securities moving into ST-ASM Stage I framework with increased margin requirements of 50% or existing margin, whichever is … | |||||||||||||||
NSE circular on securities moving into ST-ASM Stage I framework with increased margin requirements of 50% or existing margin, whichever is higher, effective January 20, 2026.
| |||||||||||||||
Rights issue listing of 48.91 crore equity shares at premium of Rs 2.05 per share | |||||||||||||||
Rights issue listing of 48.91 crore equity shares at premium of Rs 2.05 per share
| |||||||||||||||
NSE announces listing of 48.91 crore equity shares of Davangere Sugar Company Limited allotted under rights issue, effective September 3, … | |||||||||||||||
NSE announces listing of 48.91 crore equity shares of Davangere Sugar Company Limited allotted under rights issue, effective September 3, 2025.
| |||||||||||||||
BSE announces revised price bands for 12 listed companies including Alan Scott Enterprises, Clinitech Laboratory, and Davangere Sugar … | |||||||||||||||
BSE announces revised price bands for 12 listed companies including Alan Scott Enterprises, Clinitech Laboratory, and Davangere Sugar Company.
| |||||||||||||||
BSE announces revised price bands for 12 securities including Alan Scott Enterprises, Clinitech Laboratory, and Davangere Sugar Company, … | |||||||||||||||
BSE announces revised price bands for 12 securities including Alan Scott Enterprises, Clinitech Laboratory, and Davangere Sugar Company, effective August 20, 2025.
| |||||||||||||||
Rights issue announcement for Davangere Sugar Company Limited with record date August 6, 2025, offering 13 equity shares for every 25 shares … | |||||||||||||||
Rights issue announcement for Davangere Sugar Company Limited with record date August 6, 2025, offering 13 equity shares for every 25 shares held at Rs. 3.05 per share.
| |||||||||||||||
Rights issue announcement for Davangere Sugar Company Limited offering 13 equity shares for every 25 shares held at Rs. 3.05 per share. | |||||||||||||||
Rights issue announcement for Davangere Sugar Company Limited offering 13 equity shares for every 25 shares held at Rs. 3.05 per share.
| |||||||||||||||